Understanding Immune Changes and Brain Barrier Health in Alzheimer's Disease

Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease

NIH-funded research Cleveland Clinic Lerner Com-Cwru · NIH-10845542

This project looks at how immune cells and the brain's protective barrier change in people at different stages of Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-10845542 on NIH RePORTER

What this research studies

This project aims to understand how the body's immune system, both in the blood and around the brain, changes as Alzheimer's disease progresses. Researchers will examine immune cells and the health of the blood-brain barrier in individuals with early Alzheimer's, mild cognitive impairment, and full dementia, as well as in healthy older adults. By comparing these groups, we hope to learn how immune responses develop over time and how they might affect memory and thinking skills. This work could help us find new ways to detect and treat Alzheimer's disease earlier.

Who could benefit from this research

Good fit: Ideal candidates would be individuals diagnosed with preclinical Alzheimer's disease, mild cognitive impairment due to Alzheimer's, or Alzheimer's disease dementia, as well as healthy older adults.

Not a fit: Patients without Alzheimer's disease or related cognitive conditions would likely not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to new ways to identify Alzheimer's disease earlier and develop treatments that target the immune system to slow or stop its progression.

How similar studies have performed: While the role of the immune system in Alzheimer's is an active area of investigation, this project offers a novel approach by combining single-cell immune profiling with blood-brain barrier changes across different disease stages.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease biological markerAlzheimer’s disease biomarker
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.